The ISN has developed this framework in collaboration with the World Health Organization (WHO)in the context of a non-government organization with official relations with WHO. This framework outlines the requirements and operational considerations for setting up or expanding dialysis programs and is intended as a tool to support the WHO member states in developing sustainable strategies for the treatment of patients with kidney failure. This guidance covers human resource needs, infrastructure requirements, processes (forperitoneal dialysis [PD] and hemodialysis [HD]), quality assurance for dialysis as well as ancillarycare for patients with kidney failure.
Better Together – Join/Renew with the ISN Community
Advance your profession. Make a difference. Connect globally. Learn more about ISN membership options in this leaflet. As an ISN Member, you are an active participant in the worldwide kidney health community.
Following spectacular discoveries in the field of regenerative medicine, the 2nd edition features diverse novel subjects such as age/gender influences on kidney regeneration; cell senescence subverting regeneration; cell reprogramming and reconditioning in facilitating regeneration;bioengineering of kidney and its parts;therapeutic rejuvenation of the kidney cells; and the use of biologicals in kidney regeneration. A constellation of leading investigators in the field of regeneration generouslycontributed their time and effort at the time of unprecedented pandemic difficulty to the success of the 2nd edition of Regenerative Nephrology. Download PDF
Campaign Poster – World Kidney Day 2022
Kidney Health for All – Bridge the knowledge gap to better kidney care
Here you can find the WKD 2022 campaign poster. It is the graphic representation of our 2022 campaign, focusing on increasing education and awareness about kidney health to bridge the persistent and ongoing CKD knowledge gap at all level of healthcare.
Kidney Health for All – Bridge the knowledge gap to better kidney care
The toolkit contains information and resources to push out and amplify your social media campaign to raise awareness about kidney health and spread the World Kidney Day messages.
It provides you with a starting point and ideas on how to create your own social media campaign including visuals and wording that you can use for your social media posts. Explore new social media tools, such as Twitter, Instagram or Facebook Stories chats, to spread the World Kidney Day messages in your community!
The WCN’22 Visual Abstracts are developed by the Social Media Team, and approved by the abstract author, from selected WCN’22 accepted abstracts, intending to engage with our social media followers and give a glimpse of the work presented during the Congress.
Highlights the growing burden of kidney diseases and significant inequities in access to treatment across countries and regions.
Access a snapshot of individual country and regional health system characteristics and specific elements relevant to the management of patients with kidney failure in line with the WHO health systems building blocks.
Download the 2017 and 2019 GKHA reports. The reports’ findings have been and continue to feature in multiple papers. Access here.
Although early CKD identification and intervention hold promise for reducing the burden of CKD and risk factors, it remains unclear if an uniform strategy can be applicable across all income groups. The aim of this scoping review is to synthesise available evidence on early CKD identification programmes in all world regions and income groups. The study will also identify efforts that have been made to use interventions and implementation of early identification programmes for CKD across countries and income groups.
“Complement-related kidney diseases: classification, genetics and treatment”
The ISN and the Mario Negri Institute for Pharmacological Research are pleased to invite you to the 2022 ISN Frontiers Meeting in ‘Complement-related kidney diseases: classification, genetics, and treatment’ June 23-25, 2022, Bergamo, Italy.
Take advantage of a rare opportunity to present your research work to clinicians, scientists, academics, and general practitioners from around the world. Submit an abstract by March 2, 2022.
Register before March 30, 2022 to benefit from the early bird registration fees.
For more information visit the Frontiers Bergamo website.
The ISN is pleased to invite you to the 2022 ISN Frontiers Meeting on “Infections and the Kidneys”, September 22 – 25, 2022, New Delhi, India.
More than ever, the need to better understand the complex relationship between infections and kidney diseases to develop effective treatments is urgent.
Share your work in this specialty field with the international community, submit an abstract by April 20, 2022.
For more information about our four-day program and how to register, please visit our website.
The report highlights the challenges, successes, and global impact of ISN and its members in the timeframe that saw us celebrate ISN’s 60th anniversary, adopt a new brand identity, and adjust to COVID-19 restrictions.
Clinical trials provide essential evidence to guide the care of patients with kidney disease. As the global burden of kidney disease is growing, the ISN recognises the importance of supporting clinical trials around the world.
This toolkit is aimed at nephrologists and researchers in nephrology from all parts of the globe – regardless of their level of clinical trial experience and their local resources. It aims to provide a guidance for anyone wishing to start a clinical trial or to participate as a trial site. To find out how you can participate, or to provide feedback, please contact us on research@theisn.org.
Storytelling is a powerful way to inform, educate, and activate change. Help raise awareness and improve understanding of the reality of living with kidney disease by sharing your story at the ISN Community Film Event.The ISN Community Film Event is a unique initiative to raise awareness and improve understanding of the reality of living with kidney disease.
2022 Competition:
From a game-changing service providing nocturnal hemodialysis in a home-training dialysis unit in Australia to international workshops benefitting young people living with Alport Syndrome in the UK, these films present the challenging realities facing kidney disease patients. Touching, motivating, and sometimes surprising, these films all have the power to improve the lives of patients worldwide as they help raise awareness of kidney health issues.
Which of these seven films will win the “2022 ISN Film Community Best Film”? Your vote will help decide the outcome!
As a society, ISN is dedicated to advancing worldwide kidney health. A major focus of ISN activities is to build the capacity of healthcare professionals
In LMICs, the insufficient number and uneven distribution of trained professionals and equipped facilities impacts all aspects of kidney care. Therefore, ISN is striving to improve the support for prevention and increase capacity by addressing workforce shortages, developing effective multidisciplinary teams, and enhancing renal care facilities to address patients’ needs in low resource settings.
Discover here our impact in LMICs in the last decade and find out here how ISN can help.
Building Capacity
Covering the pathophysiology of renal disease along with clinical trials guiding current management guidelines
The ISN Mentorship Program is an initiative to foster mutually beneficial learning partnerships in nephrology. It connects health professionals within the ISN community, offering mentors the chance to develop coaching and leadership skills and mentees to work alongside them toward specific professional goals.
We are looking to expanding our pool of mentors: if you are an experienced nephrologist or health worker in the fields of clinical work, research, career development or another area of interest, apply here.
Receive expert guidance and hands-on training to advance new initiatives, skills or services, and community-based research or screening programs.
All above grant opportunities are open to ISN Members from Low- and Middle- Income Countries
Travere Therapeutics
ET-1 and Ang II in CKD
Join our symposium “The Link between Endothelin-1, Angiotensin II, and Proteinuria in the Pathophysiology of CKD” on Saturday, February 26, at 23:00–00:00 MYT (16:00–17:00 CET, 10:00–11:00 ET). Hear from Prof. Jonathan Barratt, Dr. Donald Kohan, and Dr. Ariela Benigni on how endothelin-1 and angiotensin II act in tandem in the pathophysiology and progression of CKD, specifically in FSGS and IgA nephropathy, and how the resulting proteinuria in these diseases is strongly associated with CKD progression. Join our panel for a breakout Q&A session directly after the symposium.
Join us at 16:30 on 26th: Genetics and the care of kidney patients
Join Dr Lim Soo Kun, Dr Moumita Barua and Dr Martin DeBorst for the Sanofi Genzyme-sponsored symposium Application of genetics in the care of kidney patients on 26th February, 16:30–17:30 (MYT). New data regarding the epidemiology of genetic kidney diseases, the importance of utilising genetic information for improved clinical decision making will be discussed, and speakers will also identify screen algorithms for detecting rare kidney disease in patients with previously unknown ethology. This is sure to be an insightful discussion, with an opportunity to ask the speakers questions.
Ultrapure Dialysis Fluid: Rise Together for Patient Safety
UPDF is a highly refined level of dialysis fluid that helps to maximize patient safety. The acceptable levels of bacteria and endotoxin in dialysis fluid have steadily decreased and the impact of impure dialysis fluid has been increasingly recognized. This culminated in the development of ISO standards (23500-5) that cover the production of UPDF.
A well-functioning dialysis unit will integrate the expertise of numerous skilled colleagues to ensure an effective patient-care approach is meticulously implemented. By doing so, multi-disciplinary teams can rise together for patient safety.
Join Drs. Adrian Liew, Jonathan Barratt and Chair Anjay Rastogi for an informative discussion on new therapeutic targets in the treatment of glomerular diseases, including new products in development from Chinook Therapeutics. Interactive Q&A session to follow the presentation.
Let’s stay in contact! Visit the B. Braun Virtual Renal Care Experience
B. Braun is one of the world’s leading manufacturers of dialysis machines and consumables for chronic dialysis treatments, acute blood purification treatments and apheresis treatments. In a constructive dialog with customers, B. Braun acts like a sparring partner to design solutions which increase efficiency, safety and therapy outcomes.
We hope you enjoy exploring our World of Renal Care. Please feel free to contact our experts.
Browse the industry programs in the e-book or website!
Join the session at the scheduled time or catch up later with on-demand viewing. Industry programs remain available until May 31, 2022 on the virtual platform.
About Industry Sessions
Industry symposia offer pertinent data on the latest scientific information and developments from the industry. Hear from leading experts on the latest advances in nephrology practices, therapies, services, and technologies.
Industry symposia are organized either virtually or in-person at the Kuala Lumpur Convention Centre.
Mark your calendars for the 2023 World Congress of Nephrology. WCN’23 will host thousands of participants, including the world’s leading experts in kidney health, to exchange the latest science and clinical applications to improve kidney care and prevent kidney disease worldwide. Hosted by the Nephrology Society of Thailand and the Asian Pacific Society of Nephrology, the ISN is pleased to bring WCN’23 to North-east Asia to help advance understanding and awareness of kidney diseases in the region.
February 2022
The ISN and the Mario Negri Institute for Pharmacological Research are pleased to invite you to the 2022 ISN Frontiers Meeting in ‘Complement-related kidney diseases: classification, genetics, and treatment’ June 23-25, 2022, Bergamo, Italy.
The report highlights the challenges, successes, and global impact of ISN and its members in the timeframe that saw us celebrate ISN’s 60th anniversary, adopt a new brand identity, and adjust to COVID-19 restrictions.
Covering the pathophysiology of renal disease along with clinical trials guiding current management guidelines
Point of Care Ultrasound (POCUS) is growing as a standard procedure and part of the contemporary examination tool for nephrologists
